Have you had a chance to explore our tools?

Consultancy

We possess a unique balance of soft skills and hard skills to help our clients tackle the most challenging issues in pharmaceutical/medical technology development and value demonstration.
We believe that our novel approach can make health technology consulting and product development more efficient, thereby helping to reduce the overall cost of healthcare

Updates and News

New Interactive Dashboard

We have launched our new Dashboard housing various applications, including Automated Literature …

US Medicare price negotiation

The US recently signed into law its historic Inflation Reduction Act, paving the way for public payer negotiation …

NICE Digital health assessment

NICE gave a positive recommendation for use to Sleepio and KardiaMobile in the areas of treatment…

Quantitative Research

Tired of the amount of time and resources indirect or quantitative research takes?  We are making conjoint …

What really is AI?

Our recently compiled database of the current and past National Essential Drugs Lists (NDRLs) in China…

Chinese Drug Database

Given all the different terminologies and classifications related to artificial intelligence…

New Interactive Dashboard

We have launched our new Dashboard housing various applications, including Automated Literature …

US Medicare price negotiation

The US recently signed into law its historic Inflation Reduction Act, paving the way for public payer negotiation …

 

NICE Digital health assessment

NICE gave a positive recommendation for use to Sleepio and KardiaMobile in the areas of treatment…

Quantitative Research

Tired of the amount of time and resources indirect or quantitative research takes?  We are making conjoint …

What really is AI?

Given all the different terminologies and classifications related to artificial intelligence…

Chinese Drug Database

Our recently compiled database of the current and past National Essential Drugs Lists (NDRLs) in China…

Explore our solutions

Strategy

Delivered a suite of services, including a value story slide deck consisting of impactful messages and supporting graphics, cost-effectiveness and budget impact models, systematic literature review to fill evidence gaps for value story and models, as well as a health technology assessment (HTA) dossier and objection handler

Read More

Analytics

Given the required timeframe, concluded that generating new data/prospective study was not feasible. Hence, shortlisted potential databases/registries already licensed that would have the required patient exposure and outcomes of interest. Analysed company’s existing UK THIN and US Truven MarketScan databases using R

Read More

Modelling

Reviewed disease area literature to understand quality of life and costs, benefit of treatment, as well as market share and revenue forecasts. Developed an integrated value assessment model (VAM) that allowed the team to test changes in the target product profile and pricing methodology on the overall value

Read More

Visualization

Reviewed current study protocols, endpoints, value messages and overall value proposition, as well as existing study trackers. Proposed our unique VNV that stored every relationship between a study, its endpoints and intended value messages as pathways along with additional supporting information in the data matrix. Click for an interactive demo:

Read More

Training

Reviewed company’s existing RWE studies and interviewed key team members to understand RWE capabilities, as well as product priorities and challenges. Developed a training workshop to empower the team to address product challenges using RWE consisting of:

Read More

Explore our solutions

 

Strategy

 

Delivered a suite of services, including a value story slide deck consisting of impactful messages and supporting graphics, cost-effectiveness and budget impact models, systematic literature review to fill evidence gaps for value story and models, as well as a health technology assessment (HTA) dossier and objection handler

 

Read More

 

Analytics

 

Given the required timeframe, concluded that generating new data/prospective study was not feasible. Hence, shortlisted potential databases/registries already licensed that would have the required patient exposure and outcomes of interest. Analysed company’s existing UK THIN and US Truven MarketScan databases using R

 

Read More

 

Modelling

 

Reviewed disease area literature to understand quality of life and costs, benefit of treatment, as well as market share and revenue forecasts. Developed an integrated value assessment model (VAM) that allowed the team to test changes in the target product profile and pricing methodology on the overall value

 

Read More

 

Visualization

 

Reviewed current study protocols, endpoints, value messages and overall value proposition, as well as existing study trackers. Proposed our unique VNV that stored every relationship between a study, its endpoints and intended value messages as pathways along with additional supporting information in the data matrix. Click for an interactive demo:

 

Read More

 

Training

 

Reviewed company’s existing RWE studies and interviewed key team members to understand RWE capabilities, as well as product priorities and challenges. Developed a training workshop to empower the team to address product challenges using RWE consisting of:

 

Read More

Newsletter

Language »